A plausible hypothesis is that lymphadenopathy reflects heightened systemic inflammation and immune activation driven by excessive cytokine production (e.g., IL-1β, IL-6, IL-18) [1,2,3,4,5,6,29]. This evidence concerns the gene IL18 and Lymphadenopathy.